-
EU Commission washes its hands of child safety issues raised in fluoride petitions
19 September 2012
ANH-Intl launches position paper to support campaign to stop drinking water fluoridation in Ireland and the UK
-
Brexit industry panel: opportunity or threat to innovation?
05 April 2017
Expert panel at NOPE 2017 looks at the potential impacts from Brexit on specialist natural products sector
-
Sugar overload places UK primary school children in the teeth of a health disaster
23 July 2014
Shocking levels of tooth decay leave young kids at risk of serious health problems
-
ANH-Intl News Alerts: Week 10, 2015
04 March 2015
Fluoride, Medical Innovation Bill quashed, Brazil’s dietary guidelines, fracking, energy drinks, GM bans and US substandard poultry
-
ANH-Intl News Alerts: Week 6, 2014
05 February 2014
ANH-Intl t-shirt campaign, supplements, Weston A. Price conference, health focus, digital eye strain, beta-blockers, raw milk, pesticides and Big Foods open-door access to ministers
-
Crisis deepens at the US Food and Drug Administration (1)
10 October 2007
The US Food and Drug Administration, rocked by controversy in recent months, has now admitted that a senior management official secretly contacted a whistleblower group.
-
Crisis deepens at the US Food and Drug Administration
03 December 2004
The US Food and Drug Administration, rocked by controversy in recent months, has now admitted that a senior management official secretly contacted a whistleblower group.
-
How many more drugs will be found unsafe?
01 December 2004
The false assumption is that drugs are far safer than dietary supplements because they have obtained approval from the FDA. This is despite the fact that the biological action of virtually every prescription drug can be duplicated with dietary supplements at less cost and greater safety.
-
NOPE's 20th birthday!
20 April 2016
London's leading industry show, Natural and Organic Products Europe, celebrates its 20th anniversary
-
Consumer Organisations Criticise Influence of Drug Companies
23 October 2004
The pharmaceutical industry operates in a way that puts profits before public health, members of parliament (MPs) heard last week. And the regulatory authorities, which are meant to ensure the safety of drugs and protect the public, collude with the industry, they were told.